AI drug synthesizer Chemify raises $50 million
Chemify, a Glasgow-based start-up that combines artificial intelligence with robotics and chemistry to rapidly make small molecules, has raised $50 million in series B funding. The oversubscribed investment round was led by Wing Venture Capital and Insight Partners. The company raised $43 million in series A funding in August 2023.
Lee Cronin, Chemify’s CEO, plans to use the new funds to accelerate the development of Chemputation, the firm’s AI system, and its robotic production platform—tools i...
Read more at cen.acs.org